Mad Money w/ Jim Cramer Mad Money w/ Jim Cramer 1/13/26
Jan 14, 2026
In this episode, Jim Cramer sits down with several industry leaders. Dr. Vass Nairosif, CEO of Novartis, shares insights on portfolio simplification and the future of radioligand therapy. Robert Bradway from Amgen discusses his company's innovative obesity drug, highlighting long-term efficacy. Dr. Leonard Schleifer of Regeneron talks about groundbreaking treatments like Dupixent and their advancements in cardiovascular risk. Jason Holler of Cardinal Health explores operational improvements and specialty distribution, emphasizing a strong financial outlook.
AI Snips
Chapters
Transcript
Episode notes
Market Mood Drives Short-Term Moves
- Markets swing on tone and narrative more than fundamentals in the short term.
- Jim Cramer warns buyers should wait a day or two after panic selloffs to buy weakness.
Wait Before Buying Panic Dips
- Wait a day or two after a major selloff before adding to positions to avoid knee-jerk panic.
- Cramer recommends gradually buying into a beaten-down name because it historically bounces back.
Tame Inflation Reignites Retail Love
- Lower inflation and tame CPI can re-ignite interest in cyclical sectors like retail and transports.
- Cramer highlights a sudden 'jailbreak' of retail love driven by buyers chasing rate-sensitive benefits.